Abcam is a producer and distributor of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in understanding health and disease.
Abcam Plc Ord 0.2P is listed on the London Stock Exchange trading with ticker code ABC.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £248,512m, with approximately 206m shares in issue. Over the last year, Abcam Plc share price has been traded in a range of 582, hitting a high of 1,588.00, and a low of 1,006.00.
Abcam Plc, officially known as Abcam Plc Ord 0.2P was formed in February of 1998, making the company twenty one years old. The company filed its latest accounts on 30th June 2014, showing a turnover of approximately 127.95 million GBX with gross profits of 90.39 million, or 0.4394 per issued share, and a pre-tax profit margin of 34.04%. Abcam Plc currently has 10 directors, and has had 10 previous directors over the last 21 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 27.02 million paid in salaries to the 734 staff (average wage of 37 thousand), with the directors receiving an average 185 thousand each. In the accounts filed in 2014, the company paid 14455000 in dividends, or 0.0703 per share. These accounts also showed Abcam Plc to have a net worth of 77.18 million, with 55.86 million held in cash.
Abcam Plc is in the Medicine and Biotech Research sector.
|Clinigen Group Plc (CLIN.L)|
|Glaxosmithkline Plc (GSK.L)|
|Dart Group Plc (DTG.L)|
|Hutchison China Meditech Limited (HCM.L)|
|Genus Plc (GNS.L)|
|Shares in Issue||206m|
|52 Week High||1,588.00|
|52 Week Low||1,006.00|